Filana Therapeutics, Inc. (FLNA) — Stock Valuation & Research

Filana Therapeutics, Inc. is a company dedicated to pioneering new pharmaceutical products and diagnostic technologies. A key area of its research is focused on creating potential treatments for Alzheimer's disease, including the investigational compounds PTI-125 and PTI-125Dx. Established by Remi Barbier in May 1998, the firm maintains its principal office in Austin, Texas.

FLNA key statistics

Price$0.57
Market cap$27.39M
SectorHealthcare
IndustryBiotechnology
ExchangeNASDAQ
52-week range0.56-3.45
Beta-0.66

Explore FLNA's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.